130 related articles for article (PubMed ID: 16526562)
1. Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy.
Sziráki I; Horváth K; Bodor N
Pharmazie; 2006 Feb; 61(2):140-3. PubMed ID: 16526562
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of a brain-enhanced chemical delivery system for estradiol.
Rahimy MH; Simpkins JW; Bodor N
Drug Des Deliv; 1990 May; 6(1):29-40. PubMed ID: 2078286
[TBL] [Abstract][Full Text] [Related]
3. New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox.
Tapfer MK; Sebestyen L; Kurucz I; Horvath K; Szelenyi I; Bodor N
Pharmacol Biochem Behav; 2004 Mar; 77(3):423-9. PubMed ID: 15006452
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum.
Rabbani O; Panickar KS; Rajakumar G; King MA; Bodor N; Meyer EM; Simpkins JW
Exp Neurol; 1997 Jul; 146(1):179-86. PubMed ID: 9225751
[TBL] [Abstract][Full Text] [Related]
5. The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation.
Rahimy MH; Anderson WR; Brewster ME; Bodor N; Simpkins JW
Endocrinology; 1991 Aug; 129(2):717-25. PubMed ID: 1855469
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a 3-substituted versus 17-substituted chemical delivery system for estradiol brain targeting.
Brewster ME; Druzgala PJ; Anderson WR; Huang MJ; Bodor N; Pop E
J Pharm Sci; 1995 Jan; 84(1):38-43. PubMed ID: 7714741
[TBL] [Abstract][Full Text] [Related]
7. Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. I. Tissue distribution.
Rahimy MH; Simpkins JW; Bodor N
Pharm Res; 1990 Oct; 7(10):1061-7. PubMed ID: 2281037
[TBL] [Abstract][Full Text] [Related]
8. Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol.
Anderson WR; Simpkins JW; Brewster ME; Bodor N
Life Sci; 1988; 42(16):1493-502. PubMed ID: 3352462
[TBL] [Abstract][Full Text] [Related]
9. Pulsed estrogen therapy: from cellular mode of action to tissue effects.
Al-Azzawi F
Climacteric; 2002 Jun; 5 Suppl 2():27-31. PubMed ID: 12482108
[TBL] [Abstract][Full Text] [Related]
10. Effects of a brain-enhanced estrogen delivery system on tail-skin temperature of the rat: implications for menopausal hot flush.
Rahimy MH; Bodor N; Simpkins JW
Maturitas; 1991 Mar; 13(1):51-63. PubMed ID: 1907349
[TBL] [Abstract][Full Text] [Related]
11. A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system.
Rahimy MH; Bodor N; Simpkins JW
J Steroid Biochem; 1989 Aug; 33(2):179-87. PubMed ID: 2770295
[TBL] [Abstract][Full Text] [Related]
12. A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat.
Estes KS; Keuth V; Dietzel K; Brewster ME; Bodor NS; Derendorf H
Pharm Res; 1991 Sep; 8(9):1180-5. PubMed ID: 1788164
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system.
Yiu S; Knaus EE
J Med Chem; 1996 Nov; 39(23):4576-82. PubMed ID: 8917646
[TBL] [Abstract][Full Text] [Related]
14. A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats.
Estes KS; Brewster ME; Simpkins JW; Bodor N
Life Sci; 1987 Mar; 40(13):1327-34. PubMed ID: 3561153
[TBL] [Abstract][Full Text] [Related]
15. Suppression of plasma testosterone and prostate carcinoma size by a redox-based, brain-targeted estrogen delivery system in the rat.
Rahimy MH; Bodor N; Simpkins JW
Prostate; 1993; 23(1):79-90. PubMed ID: 8337187
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats.
Mullersman G; Derendorf H; Brewster ME; Estes KS; Bodor N
Pharm Res; 1988 Mar; 5(3):172-7. PubMed ID: 3244629
[TBL] [Abstract][Full Text] [Related]
17. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
Sahlin L; Masironi B; Akerberg S; Eriksson H
Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
[TBL] [Abstract][Full Text] [Related]
18. Lack of estradiol modulation of sleep deprivation-induced c-Fos in the rat brain.
Mashoodh R; Stamp JA; Wilkinson M; Rusak B; Semba K
Physiol Behav; 2008 Nov; 95(4):562-9. PubMed ID: 18761364
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostatic glutathione-peroxidase (GSH-PO) in the rat treated with a combination of testosterone and 17beta-estradiol.
Murakoshi M; Ikada R; Tagawa M
Tokai J Exp Clin Med; 2003 Jul; 28(2):45-50. PubMed ID: 14714828
[TBL] [Abstract][Full Text] [Related]
20. Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats.
Pluchino N; Merlini S; Cubeddu A; Giannini A; Bucci F; Casarosa E; Cela V; Angioni S; Luisi M; Genazzani AR
Menopause; 2009; 16(5):1037-43. PubMed ID: 19295450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
